Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.

Journal of neurology, neurosurgery, and psychiatry - 1 Dec 1999

Gläsker S, Bender B U, Apel T W, Natt E, van Velthoven V, Scheremet R, Zentner J, Neumann H P

Abstract excerpt

OBJECTIVES: Haemangioblastoma of the CNS occurs as a sporadic entity and as a manifestation of the autosomal dominant von Hippel-Lindau disease with the major additional components retinal angioma, renal cancer, and pheochromocytoma. Genetic testing for germline mutations predisposing to von Hippel-Lindau disease has been available since identification of the VHL tumour suppressor gene. The impact of this testing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Axons
Share to Cerebellar Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemangioblastoma

Share to Hemangioma

Share to Molecular Biology

Share to Pheochromocytoma

Share to Retinal Neoplasms

Share to von Hippel-Lindau Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 10567493
DOI: 10.1136/jnnp.67.6.758
PMCID: PMC1736691

Genes

VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.PMID 10567493Read ↗

VHL mutation analysis in patients with isolated central nervous system haemangioblastomaSemantic proximity Read ↗

Von Hippel‐Lindau SyndromeSemantic proximity Read ↗

Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.Semantic proximity Read ↗

Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.Semantic proximity Read ↗

Clinical and molecular features of familial and sporadic cases of von Hippel-Lindau disease from Mexico.Semantic proximity Read ↗

[Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].Semantic proximity Read ↗

Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features.Semantic proximity Read ↗

A genetic register for von Hippel-Lindau disease.Semantic proximity Read ↗

Molecular genetic analysis of von Hippel-Lindau disease.Semantic proximity Read ↗

[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].Semantic proximity Read ↗

Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system.Semantic proximity Read ↗

[Retinal capillary angioma. Clinical and molecular genetic studies].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.